Hepatitis B Response of Premature Infants after Primary and Booster Immunisation with a Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Poliovirus/<i>Haemophilus Influenzae</i> Type B Vaccine : Table 5

]>Hepatitis B Response of Premature Infants after Primary and Booster Immunisation with a Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Poliovirus/<i>Haemophilus Influenzae</i> Type B Vaccine : Table 5

Table 5: Anti-HBs concentrations (mIU/ml) after all HBV doses in subjects who were non-responders to hepatitis B at the end of the primary and booster studies.


										Post Extra HBV			HBV
Gestational age (Weeks)	Birth weight (kg)	Percentile at birth	Weight at 1st vaccination (kg)	Percentile at 6 months	Weight at 6 months (kg)	Pre-primary	Post-primary	Pre-booster	Post-booster	Dose 1	Dose 2	Dose 3	Persistence at 4 years (mIU/ml)

33	2.1	75	4.4	95	8.3	10	10	10	10	690	3485	NG	176
35	2.0	25	4	25	6.7	10	10	10	10	10	10	32	128
32	0.6	10	1.7	5	4.4	10	10	10	10	10	141	NG	64
31	0.8	10	1.7	10	5.1	97	10	10	10	10	NA	NG	10
33	2.0	50	4.3	>90	8.4	10	10	10	10	10	10	10	10
35	1.7	10	3.6	50	6.6	10	10	10	10	10	1087	NG	NA

NA = Not available; NG = Not given.